Transcranial sonography in brain disorders with trace metal accumulation

International Review of Neurobiology

Volumn 90, Issue C, 2010, Pages 166-178

  Walter, Uwe ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Basal ganglia; Copper; Iron; Lenticular nucleus; Manganese; Substantia nigra; Transcranial sonography

Indexed keywords

COPPER; IRON; MANGANESE; TRACE METAL;

ARTICLE; BASAL GANGLION; BIOACCUMULATION; BRAIN DISEASE; COPPER METABOLISM; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOPPLER ECHOGRAPHY; DYSTONIA; GLOBUS PALLIDUS; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; IRON METABOLISM; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NEUROIMAGING; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PUTAMEN; SENSITIVITY ANALYSIS; SUBSTANTIA NIGRA; THALAMUS; WILSON DISEASE;

EID: 77955348036     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(10)90012-3     Document Type: Chapter

References (63)

1. Akbas N., Hochstrasser H., Deplazes J., Tomiuk J., Bauer P., Walter U., Behnke S., Riess O., Berg D. Screening for mutations of the HFE gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra. Neurosci. Lett. 2006, 407:16-19.
2. Arduino D., Silva D., Cardoso S.M., Chaves S., Oliveira C.R., Santos M.A. New hydroxypyridinone iron-chelators as potential anti-neurodegenerative drugs. Front Biosci. 2008, 13:6763-6774.
3. Astrakas L.G., Konitsiotis S., Margariti P., Tsouli S., Tzarouhi L., Argyropoulou M.I. T2 relaxometry and fMRI of the brain in late-onset restless legs syndrome. Neurology 2008, 71:911-916.
4. Bandmann O., Asmus F., Sibbing D., Grundmann M., Schwab S.G., Müller J., Wildenauer D.B., Poewe W., Gasser T., Oertel W.H. Copper genes are not implicated in the pathogenesis of focal dystonia. Neurology 2002, 59:782-783.
5. Becker G., Berg D. Neuroimaging in basal ganglia disorders: Perspectives for transcranial ultrasound. Mov. Disord. 2001, 16:23-32.
6. Becker G., Seufert J., Bogdahn U., Reichmann H., Reiners K. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 1995, 45:182-184.
7. Becker G., Naumann M., Scheubeck M., Hofmann E., Deimling M., Lindner A., Gahn G., Reiners C., Toyka K.V., Reiners K. Comparison of transcranial sonography, magnetic resonance imaging, and single photon emission computed tomography findings in idiopathic spasmodic torticollis. Mov. Disord. 1997, 12:79-88.
8. Becker G., Berg D., Rausch W.D., Lange H.K., Riederer P., Reiners K. Increased tissue copper and manganese content in the lentiform nucleus in primary adult-onset dystonia. Ann. Neurol. 1999, 46:260-263.
9. Becker G., Berg D., Francis M., Naumann M. Evidence for disturbances of copper metabolism in dystonia: From the image towards a new concept. Neurology 2001, (57):2290-2294.
10. Berg D., Grote C., Rausch W.D., Mäurer M., Wesemann W., Riederer P., Becker G. Iron accumulation in the substantia nigra in rats visualized by ultrasound. Ultrasound Med. Biol. 1999, 25:901-904.
11. Berg D., Hoggenmüller U., Hofmann E., Fischer R., Kraus M., Scheurlen M., Becker G. The basal ganglia in haemochromatosis. Neuroradiology 2000, 42:9-13.
12. Berg D., Weishaupt A., Francis M.J., Miura N., Yang X.L., Goodyer I.D., Naumann M., Koltzenburg M., Reiners K., Becker G. Changes of copper-transporting proteins and ceruloplasmin in the lentiform nuclei in primary adult-onset dystonia. Ann. Neurol. 2000, 47:827-830.
13. Berg D., Siefker C., Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J. Neurol. 2001, 248:684-689.
14. Berg D., Gerlach M., Youdim M.B., Double K.L., Zecca L., Riederer P., Becker G. Brain iron pathways and their relevance to Parkinson's disease. J. Neurochem. 2001, 79:225-236.
15. Berg D., Roggendorf W., Schröder U., Klein R., Tatschner T., Benz P., Tucha O., Preier M., Lange K.W., Reiners K., Gerlach M., Becker G. Echogenicity of the substantia nigra: Association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch. Neurol. 2002, 59:999-1005.
16. Berg D., Merz B., Reiners K., Naumann M., Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov. Disord. 2005, 20:383-385.
17. Berg D. Ultrasound in the (premotor) diagnosis of Parkinson's disease. Parkinsonism Relat. Disord. 2007, 13(Suppl. 3):S429-S433.
18. Berg D., Godau J., Walter U. Transcranial sonography in movement disorders. Lancet Neurol. 2008, 7:1044-1055.
19. Connor J.R., Snyder B.S., Arosio P., Loeffler D.A., LeWitt P. A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J. Neurochem. 1995, 65:717-724.
20. Deplazes J., Schöbel K., Hochstrasser H., Bauer P., Walter U., Behnke S., Spiegel J., Becker G., Riess O., Berg D. Screening for mutations of the IRP2 gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra. J. Neural. Transm. 2003, 111:515-521.
21. Dexter D.T., Carayon A., Javoy-Agid F., Agid Y., Wells F.R., Daniel S.E., Lees A.J., Jenner P., Marsden C.D. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991, 114:1953-1975.
22. Earley C.J., Ponnuru P., Wang X., Patton S.M., Conner J.R., Beard J.L., Taub D.D., Allen R.P. Altered iron metabolism in lymphocytes from subjects with restless legs syndrome. Sleep 2008, 31:847-852.
23. Felletschin B., Bauer P., Walter U., Behnke S., Spiegel J., Csoti I., Sommer U., Zeiler B., Becker G., Riess O., Berg D. Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra. Neurosci. Lett. 2003, 352:53-56.
24. GaŁazka-Friedman J., Friedman A. Controversies about iron in parkinsonian and control substantia nigra. Acta Neurobiol. Exp. (Wars) 1997, 57:217-225.
25. Godau J., Schweitzer K.J., Liepelt I., Gerloff C., Berg D. Substantia nigra hypoechogenicity: Definition and findings in restless legs syndrome. Mov. Disord. 2007, 22:187-192.
26. Godau J., Klose U., Di Santo A., Schweitzer K., Berg D. Multiregional brain iron deficiency in restless legs syndrome. Mov. Disord. 2008, 23:1184-1187.
27. Hagenah J.M., König I.R., Becker B., Hilker R., Kasten M., Hedrich K., Pramstaller P.P., Klein C., Seidel G. Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles. J. Neurol. 2007, 254:1407-1413.
28. Hallgren B., Sourander P. The effect of age on the non-haemin iron in the human brain. J. Neurochem. 1958, 3:41-51.
29. Hirsch E.C. Altered regulation of iron transport and storage in Parkinson's disease. J. Neural. Transm. 2006, 71(Suppl.):201-204.
30. Hochstrasser H., Bauer P., Walter U., Behnke S., Spiegel J., Csoti I., Zeiler B., Bornemann A., Pahnke J., Becker G., Riess O., Berg D. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson's disease. Neurology 2004, 63:1912-1917.
31. Hochstrasser H., Tomiuk J., Walter U., Behnke S., Spiegel J., Krüger R., Becker G., Riess O., Berg D. Functional relevance of ceruloplasmin mutations in Parkinson's disease. FASEB J. 2005, 19:1851-1853.
32. Huang Y.W., Jeng J.S., Tsai C.F., Chen L.L., Wu R.M. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease. Mov. Disord. 2007, 22:550-555.
33. Jankovic J. Searching for a relationship between manganese and welding and Parkinson's disease. Neurology 2005, 64:2021-2028.
34. Josephs K.A., Ahlskog J.E., Klos K.J., Kumar N., Fealey R.D., Trenerry M.R., Cowl C.T. Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology 2005, 64:2033-2039.
35. Kim J.Y., Kim S.T., Jeon S.H., Lee W.Y. Midbrain transcranial sonography in Korean patients with Parkinson's disease. Mov. Disord. 2007, 22:1922-1926.
36. King A.D., Walshe J.M., Kendall B.E., Chinn R.J., Paley M.N., Wilkinson I.D., Halligan S., Hall-Craggs M.A. Cranial MR imaging in Wilson's disease. AJR Am. J. Roentgenol. 1996, 167:1579-1584.
37. Kohno S., Miyajima H., Takahashi Y., Inoue Y. Aceruloplasminemia with a novel mutation associated with parkinsonism. Neurogenetics 2000, 2:237-238.
38. Kolevski G., Petrov I., Petrova V. Transcranial sonography in the evaluation of Parkinson disease. J. Ultrasound Med. 2007, 26:509-512.
39. Kruse N., Berg D., Francis M.J., Naumann M., Rausch W.D., Reiners K., Rieckmann P., Weishaupt A., Becker G. Reduction of Menkes mRNA and copper in leukocytes of patients with primary adult-onset dystonia. Ann. Neurol. 2001, 49:405-408.
40. Mena I., Marin O., Fuenzalida S., Cotzias G.C. Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology. 1967, 17:128-136.
41. Morris C.M., Candy J.M., Oakley A.E., Bloxham C.A., Edwardson J.A. Histochemical distribution of non-haem iron in the human brain. Acta Anat. (Basel). 1992, 144:235-257.
42. Naumann M., Becker G., Toyka K.V., Supprian T., Reiners K. Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography. Neurology 1996, 47:1284-1290.
43. Oakley A.E., Collingwood J.F., Dobson J., Love G., Perrott H.R., Edwardson J.A., Elstner M., Morris C.M. Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology 2007, 68:1820-1825.
44. Oder W., Prayer L., Grimm G., Spatt J., Ferenci P., Kollegger H., Schneider B., Gangl A., Deecke L. Wilson's disease: evidence of subgroups derived from clinical findings and brain lesions. Neurology 1993, 43:120-124.
45. Okawa M., Miwa H., Kajimoto Y., Hama K., Morita S., Nakanishi I., Kondo T. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations. Intern. Med. 2007, 46:1527-1531.
46. Qian Z.M., Ke Y. Rethinking the role of ceruloplasmin in brain iron metabolism. Brain Res. Brain Res. Rev. 2001, 35:287-294.
47. Ressner P., Skoloudik D., Hlustik P., Kanovsky P. Echogenicity of substantia nigra in Parkinson's disease-pilot study. J. Neuroimaging. 2007, 17:164-167.
48. Rossi L., Lombardo M.F., Ciriolo M.R., Rotilio G. Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance. Neurochem. Res. 2004, 29:493-504.
49. Ruprecht-Dörfler P., Berg D., Tucha O., Benz P., Meier-Meitinger M., Alders G.L., Lange K.W., Becker G. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. Neuroimage 2003, 18:416-422.
50. Sadek A.H., Rauch R., Schulz P.E. Parkinsonism due to manganism in a welder. Int. J. Toxicol. 2003, 22:393-401.
51. Schmidauer C., Sojer M., Seppi K., Stockner H., Högl B., Biedermann B., Brandauer E., Peralta C.M., Wenning G.K., Poewe W. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann. Neurol. 2005, 58:630-634.
52. Stockner H., Sojer M., Seppi K., Mueller J., Wenning G.K., Schmidauer C., Poewe W. Midbrain sonography in patients with Essential Tremor. Mov. Disord. 2007, 22:414-417.
53. Spiegel J., Hellwig D., Möllers M.O., Behnke S., Jost W., Fassbender K., Samnick S., Dillmann U., Becker G., Kirsch C.M. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease. Brain 2006, 129:1188-1193.
54. Walter U., Wittstock M., Benecke R., Dressler D. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J. Neural. Transm. 2002, 109:191-196.
55. Walter U., Krolikowski K., Tarnacka B., Benecke R., Czlonkowska A., Dressler D. Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease. Neurology 2005, 64:1726-1732.
56. Walter U., Dressler D., Wolters A., Wittstock M., Benecke R. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease. Mov Disord. 2007, 22:48-54.
57. Walter U., Behnke S., Eyding J., Niehaus L., Postert T., Seidel G., Berg D. Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound Med Biol. 2007, 33:15-25.
58. Walter U., Kanowski M., Kaufmann J., Grossmann A., Benecke R., Niehaus L. Contemporary ultrasound systems allow high-resolution transcranial imaging of small echogenic deep intracranial structures similarly as MRI: A phantom study. Neuroimage. 2008, 40:551-558.
59. Walter U., Dressler D., Lindemann C., Slachevsky A., Miranda M. Transcranial sonography findings in welding-related Parkinsonism in comparison to Parkinson's disease. Mov. Disord. 2008, 23:141-145.
60. Walter U., Wagner S., Horowski S., Benecke R., Zettl U.K. Transcranial brain sonography findings predict disease progression in multiple sclerosis. Neurology 2009, 73:1010-1017.
61. Walter U. Transcranial brain sonography findings in Parkinson's disease: implications for pathogenesis, early diagnosis and therapy. Expert Rev. Neurother. 2009, 9:835-846.
62. Xu Q., Kanthasamy A.G., Reddy M.B. Neuroprotective effect of the natural iron chelator, phytic acid in a cell culture model of Parkinson's disease. Toxicology. 2008, 245:101-108.
63. Zecca L., Berg D., Arzberger T., Ruprecht P., Rausch W.D., Musicco M., Tampellini D., Riederer P., Gerlach M., Becker G. In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov. Disord. 2005, 20:1278-1285.